Federal Capture Intelligence

In-Vitro Diagnostic Substance Manufacturing contractors at the Department of Health and Human Services

Contract actions: October 1, 2021 – July 27, 2026 Updated July 28, 2026 Department of Health and Human Services agency guide NAICS 325413 · In-Vitro Diagnostic Substance Manufacturing
Latest 12 months
$12.6M
Net obligations · Down $21.5M vs. $34.1M preceding
Prime contractors
66
With positive obligations in the latest 12 months

Market snapshot for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Federal records show $1.3B in net obligations across 2,039 awards in In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services from Oct 1, 2021 through Jul 27, 2026. This market accounts for 0.94% of $140.6B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 63.1% from $34.1M to $12.6M. 17 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $10.5M versus $7.8M through the same date in FY25 (+35.8%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$89.0M744Complete
FY2023$1.2B759Complete
FY2024$30.0M688Complete
FY2025$9.8M565Complete
FY2026$10.5M266YTD through Jul 27, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$1.3B
2,039 awards · 278 prime contractors
Latest 12-month movement
−63.1%
$12.6M vs. $34.1M
Leading eight prime share
66.2%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
0.94% of $140.6B in agency-wide net obligations.
Set-aside share when reported
5.5% of 1,495 awards with reported set-aside status.
Set-aside reporting
82 set aside · 1,413 no set-aside · 544 not reported

What changed in the last 12 months?

Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.

Competitive shifts

CEPHEID gained the most market share
3.4%→34.1%+30.7 percentage points
The contractor now ranks #1 by positive obligations, based on 31 reported actions.
ATLANTIC TRADING LLC had no reported activity in the latest 12 months
$26.6M→$0No latest-period activity
It previously ranked #1 by positive obligations, based on 4 reported actions.
BIOTEKE USA, LLC recorded the largest net deobligation
$3.7M→−$1.6M−$5.3M
The contractor now is unranked by positive obligations, based on 1 reported action.

Market structure

Top-five contractor share decreased
75.7%→59.3%−16.4 percentage points
Contractors outside the top five now account for 40.7% of positive obligations.

Buyer demand

Reported obligations through CDC OFFICE OF ACQUISITION SERVICES decreased
$2.3M→$874K−$1.4M
Latest-period activity spans 25 awards across 18 prime contractors.
Reported obligations through ALBUQUERQUE AREA INDIAN HEALTH SVC increased
$1.1M→$2.3M+$1.2M
Latest-period activity spans 21 awards across 6 prime contractors.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Funding pattern for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.

28.3% of positive obligations were attributed to PHOENIX AREA INDIAN HEALTH SVC. That represents $4.1M, up $5.7M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. PHOENIX AREA INDIAN HEALTH SVC28.3% · $4.1M · up $5.7M
  2. ALBUQUERQUE AREA INDIAN HEALTH SVC15.6% · $2.3M · up $1.2M
  3. FDA OFFICE OF ACQ GRANT SVCS14.3% · $2.1M · down $592K
  4. NAVAJO AREA INDIAN HEALTH SVC7.4% · $1.1M · down $711K
  5. NATIONAL INSTITUTES OF HEALTH - CC6.9% · $994K · down $1.0M
  6. All other reported offices27.6% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    PHOENIX AREA INDIAN HEALTH SVC

    #1New to the positive-obligation ranking

    Latest 12 months

    $4.1M

    28.3% of positive obligations

    Versus preceding 12 months

    +$5.7M

    11 active prime contractors · 36 awards

    View office comparison and evidence

    Reported obligations moved from $1.6M in net deobligations to $4.1M in net obligations. The office’s share of positive obligations moved from 0% to 28.3%, a change of +28.3 percentage points.

    The latest period contains 39 actions across 36 awards and 1 newly active prime contractor. The preceding period contained 17 active prime contractors and 69 awards.

  2. Reported funding office

    ALBUQUERQUE AREA INDIAN HEALTH SVC

    #2Up 4 from #6

    Latest 12 months

    $2.3M

    15.6% of positive obligations

    Versus preceding 12 months

    +$1.2M

    6 active prime contractors · 21 awards

    View office comparison and evidence

    Reported obligations increased 107.5% from $1.1M to $2.3M. The office’s share of positive obligations moved from 2.4% to 15.6%, a change of +13.2 percentage points.

    The latest period contains 37 actions across 21 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 33 awards.

  3. Reported funding office

    FDA OFFICE OF ACQ GRANT SVCS

    #3Down 1 from #2

    Latest 12 months

    $2.1M

    14.3% of positive obligations

    Versus preceding 12 months

    −$592K

    7 active prime contractors · 41 awards

    View office comparison and evidence

    Reported obligations decreased 22.2% from $2.7M to $2.1M. The office’s share of positive obligations moved from 5.9% to 14.3%, a change of +8.4 percentage points.

    The latest period contains 44 actions across 41 awards and 2 newly active prime contractors. The preceding period contained 7 active prime contractors and 28 awards.

  4. Reported funding office

    NAVAJO AREA INDIAN HEALTH SVC

    #4Up 1 from #5

    Latest 12 months

    $1.1M

    7.4% of positive obligations

    Versus preceding 12 months

    −$711K

    26 active prime contractors · 63 awards

    View office comparison and evidence

    Reported obligations decreased 40.1% from $1.8M to $1.1M. The office’s share of positive obligations moved from 3.9% to 7.4%, a change of +3.5 percentage points.

    The latest period contains 100 actions across 63 awards and 2 newly active prime contractors. The preceding period contained 32 active prime contractors and 77 awards.

  5. Reported funding office

    NATIONAL INSTITUTES OF HEALTH - CC

    #5Down 1 from #4

    Latest 12 months

    $994K

    6.9% of positive obligations

    Versus preceding 12 months

    −$1.0M

    25 active prime contractors · 33 awards

    View office comparison and evidence

    Reported obligations decreased 50.5% from $2.0M to $994K. The office’s share of positive obligations moved from 4.4% to 6.9%, a change of +2.5 percentage points.

    The latest period contains 36 actions across 33 awards and 5 newly active prime contractors. The preceding period contained 50 active prime contractors and 94 awards.

  6. Reported funding office

    CDC OFFICE OF ACQUISITION SERVICES

    #6Down 3 from #3

    Latest 12 months

    $874K

    6.0% of positive obligations

    Versus preceding 12 months

    −$1.4M

    18 active prime contractors · 25 awards

    View office comparison and evidence

    Reported obligations decreased 62.4% from $2.3M to $874K. The office’s share of positive obligations moved from 5.1% to 6.0%, a change of +0.9 percentage points.

    The latest period contains 28 actions across 25 awards and 5 newly active prime contractors. The preceding period contained 28 active prime contractors and 39 awards.

  7. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #7Up 1 from #8

    Latest 12 months

    $449K

    3.1% of positive obligations

    Versus preceding 12 months

    −$83K

    10 active prime contractors · 13 awards

    View office comparison and evidence

    Reported obligations decreased 15.7% from $532K to $449K. The office’s share of positive obligations moved from 1.2% to 3.1%, a change of +1.9 percentage points.

    The latest period contains 15 actions across 13 awards and 9 newly active prime contractors. The preceding period contained 6 active prime contractors and 6 awards.

  8. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    #8New to the positive-obligation ranking

    Latest 12 months

    $415K

    2.9% of positive obligations

    Versus preceding 12 months

    +$7.7M

    3 active prime contractors · 3 awards

    View office comparison and evidence

    Reported obligations moved from $7.2M in net deobligations to $415K in net obligations. The office’s share of positive obligations moved from 0% to 2.9%, a change of +2.9 percentage points.

    The latest period contains 7 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 4 active prime contractors and 5 awards.

    Leading award-level changes

  9. Reported funding office

    NIH NCI

    #9Down 2 from #7

    Latest 12 months

    $388K

    2.7% of positive obligations

    Versus preceding 12 months

    −$238K

    5 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations decreased 38.0% from $625K to $388K. The office’s share of positive obligations moved from 1.4% to 2.7%, a change of +1.3 percentage points.

    The latest period contains 7 actions across 7 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 22 awards.

  10. Reported funding office

    NATIONAL INSTITUTES OF HEALTH OLAO

    #10Up 7 from #17

    Latest 12 months

    $344K

    2.4% of positive obligations

    Versus preceding 12 months

    +$291K

    11 active prime contractors · 12 awards

    View office comparison and evidence

    Reported obligations increased 547.4% from $53K to $344K. The office’s share of positive obligations moved from 0.12% to 2.4%, a change of +2.3 percentage points.

    The latest period contains 12 actions across 12 awards and 11 newly active prime contractors. The preceding period contained 3 active prime contractors and 4 awards.

  11. Reported funding office

    OFC ASST SEC FOR PREPARENESS RES

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    +$2.4M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations moved from $2.4M in net deobligations to $0 in net obligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 8 active prime contractors and 8 awards.

  12. Reported funding office

    INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC)

    No positive-obligation rank

    Latest 12 months

    $0

    0% of positive obligations

    Versus preceding 12 months

    −$32.7M

    0 active prime contractors · 0 awards

    View office comparison and evidence

    Reported obligations decreased 100.0% from $32.7M to $0. The office’s share of positive obligations moved from 72.0% to 0%, a change of −72.0 percentage points.

    The latest period contains 0 actions across 0 awards. The preceding period contained 4 active prime contractors and 5 awards.

    Leading award-level changes

  13. Reported funding office

    ASPR/DAAPPO/ORM HQ

    No positive-obligation rank

    Latest 12 months

    −$1.6M

    0% of positive obligations

    Versus preceding 12 months

    −$1.6M

    1 active prime contractor · 1 award

    View office comparison and evidence

    Reported obligations moved from $0 in net obligations to $1.6M in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.

    The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 4 active prime contractors and 4 awards.

How this work is bought

Reported award structure, competition, pricing, work categories, and contracting channels for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services.

During Jul 28, 2025–Jul 27, 2026, this market recorded $18.2M in positive net award obligations across 179 awards. The leading reported procedure, Simplified Acquisition, accounted for 66.3% of that positive-obligation base. Awards with a reported parent IDV accounted for 58.5%.

Leading award type
41.5%
Purchase Order
Leading reported procedure
66.3%
Simplified Acquisition
Reported parent IDV
58.5%
of positive obligations had a reported parent IDV
Median reported offers
1
146 of 179 awards reported offers

Buying method changes

Compared with Jul 28, 2024–Jul 27, 2025. Based on 179 current awards and 308 preceding awards with positive net obligations.

Leading reported procedure
Simplified Acquisition
Previously Only One Source · 64.3% preceding vs 66.3% current
Parent-IDV obligation share
58.5%
Up from 25.5% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 325413 peer median, parent-IDV obligation share is 18.2 percentage points lower, reported full-and-open obligation share is 8.7 percentage points higher, delivery-order obligation share is 22.5 percentage points lower, and median positive award obligations are 20.4% lower.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share58.5%76.7%-18.2 pts
Reported full-and-open obligation share18.4%9.7%+8.7 pts
Delivery-order obligation share22.9%45.3%-22.5 pts
Median positive award obligations$36K$45K-20.4%
Peer cohort and comparison limits

The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Purchase Order(B)95$7.6M41.5%
BPA Call(A)44$6.5M35.6%
Delivery Order(C)40$4.2M22.9%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
BPA(E)44$6.5M35.6%
IDC(B)27$2.6M14.0%
FSS(C)13$1.6M8.8%
Not reported95$7.6M41.5%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)71$9.0M49.6%
Multiple Award(M)13$1.6M8.8%
Not reported95$7.6M41.5%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Simplified Acquisition(SP1)119$12.1M66.3%
Subject To Multiple Award Fair Opportunity(MAFO)19$3.3M18.0%
Only One Source(SSS)40$2.8M15.3%
Negotiated Proposal/Quote(NP)1$68K0.37%

Extent competed

Reported valueAwardsPositive obligationsShare
Competed Under SAP(F)74$8.7M47.6%
Not Competed Under SAP(G)45$3.4M18.8%
Full And Open Competition(A)20$3.4M18.4%
Not Competed(C)40$2.8M15.3%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Only One Source - Other(ONE)14$2.8M15.4%
Fair Opportunity Given(FAIR)5$473K2.6%
Not reported160$14.9M82.0%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
SAP Non-Competition (FAR 13)(SP2)41$3.2M17.5%
Only One Source-Other (FAR 6.302-1 Other)(ONE)38$2.6M14.3%
Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH)4$236K1.3%
Unique Source (FAR 6.302-1(B)(1))(UNQ)2$173K0.95%
Not reported94$12.0M66.0%

Contract pricing types

Reported valueAwardsPositive obligationsShare
Firm Fixed Price(J)179$18.2M100.0%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets(6550)77$9.7M53.1%
Medical And Surgical Instruments, Equipment, And Supplies(6515)11$3.9M21.6%
Laboratory Equipment And Supplies(6640)51$2.9M16.1%
Drugs And Biologicals(6505)15$846K4.6%
Maint/Repair/Rebuild Of Equipment- Instruments And Laboratory Equipment(J066)10$261K1.4%
Hospital Furniture, Equipment, Utensils, And Supplies(6530)3$147K0.81%
Other reported values12$434K2.4%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
Indian Health Service(7527)60$10.8M59.3%
National Institutes of Health(7529)75$3.9M21.5%
Food and Drug Administration(7524)26$2.1M11.5%
Centers for Disease Control and Prevention(7523)17$979K5.4%
Office of Assistant Secretary for Preparedness and Response(7505)1$430K2.4%

Awarding offices

Reported valueAwardsPositive obligationsShare
Phoenix Area Indian Health Svc(75H712)20$6.0M32.7%
Albuquerque Area Indian Health Svc(75H707)9$2.5M14.0%
Fda Office Of Acq Grant Svcs(75F401)26$2.1M11.5%
Navajo Area Indian Health Svc(75H710)25$2.0M11.1%
National Institutes Of Health - Cc(75N900)15$1.2M6.8%
National Institutes Of Health Olao(75N980)17$1.1M5.9%
Other reported values67$3.3M18.1%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75H71223A00001(7527)6$3.2M17.8%
75F40123D00001(7524)19$1.7M9.4%
75H71224A00007(7527)4$1.3M7.3%
36F79718D0395(3600)2$671K3.7%
75N98022A00032(7529)24$528K2.9%
36F79724D0020(3600)1$457K2.5%
75H71221A00002(7527)1$400K2.2%
75H71221A00014(7527)1$250K1.4%
Other reported values26$2.1M11.3%
Not reported95$7.6M41.5%

Offers, award size, and timing

Median reported offers
1 median
146 reported · 33 not reported
Positive award obligations
$36K median
$23K–$100K middle 50%
Reported performance period
364 days (~12 months) median
179 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Prime contractors for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Latest 12-month concentration and complete prime contractor rankings across the period shown.

Prime contractor concentration
17 of 66prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
34.1%of positive obligations in the last 12 months
Leading four prime contractors
56.5%of positive obligations in the last 12 months
Leading eight prime contractors
66.2%of positive obligations in the last 12 months

Based on $15.2M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $5.2M

    34.1%

    Dollar movement

    +$3.6M

    vs. prior 12 months

    Last 12mo awards

    20 awards

    31 actions

    Historical and award details for CEPHEID
    Obligations: prior → latest
    $1.6M → $5.2M
    +218.7%
    Share: prior → latest
    3.4% → 34.1%
    +30.7 percentage points
    All-period obligations
    $19.3M
    1.4% of all-period positive obligations · 73 awards
    Recorded activity
    Since Dec 6, 2021
    through Jul 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside2027
    Not reported08
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $1.8M

    12.1%

    Dollar movement

    −$480K

    vs. prior 12 months

    Last 12mo awards

    30 awards

    33 actions

    Historical and award details for ILLUMINA, INC.
    Obligations: prior → latest
    $2.3M → $1.8M
    −20.8%
    Share: prior → latest
    4.9% → 12.1%
    +7.2 percentage points
    All-period obligations
    $12.0M
    0.90% of all-period positive obligations · 129 awards
    Recorded activity
    Since Mar 25, 2022
    through Jul 21, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside38
    Not reported2716
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $991K

    6.5%

    Dollar movement

    −$395K

    vs. prior 12 months

    Last 12mo awards

    17 awards

    19 actions

    Historical and award details for BIOMERIEUX INC
    Obligations: prior → latest
    $1.4M → $991K
    −28.5%
    Share: prior → latest
    2.9% → 6.5%
    +3.6 percentage points
    All-period obligations
    $4.4M
    0.33% of all-period positive obligations · 58 awards
    Recorded activity
    Since Oct 26, 2021
    through Jul 21, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside911
    Not reported88
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $563K

    3.7%

    Dollar movement

    −$722K

    vs. prior 12 months

    Last 12mo awards

    27 awards

    27 actions

    Historical and award details for 10X GENOMICS, INC.
    Obligations: prior → latest
    $1.3M → $563K
    −56.2%
    Share: prior → latest
    2.7% → 3.7%
    +1.0 percentage points
    All-period obligations
    $6.6M
    0.49% of all-period positive obligations · 258 awards
    Recorded activity
    Since Dec 30, 2021
    through Jun 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside02
    Reported no set-aside2756
    Not reported00
    Reported small business18
    All-period set-aside types
    • 22 · Total small business
  5. #5

    Last 12mo obligations

    $430K

    2.8%

    Dollar movement

    +$257K

    vs. prior 12 months

    Last 12mo awards

    1 award

    3 actions

    Historical and award details for ORASURE TECHNOLOGIES INC
    Obligations: prior → latest
    $174K → $430K
    +147.8%
    Share: prior → latest
    0.37% → 2.8%
    +2.5 percentage points
    All-period obligations
    $542K
    0.040% of all-period positive obligations · 6 awards
    Recorded activity
    Since Feb 28, 2022
    through Jul 1, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside13
    Not reported00
    Reported small business13
    All-period set-aside types
    • 1 · Total small business
  6. #6

    Last 12mo obligations

    $424K

    2.8%

    Dollar movement

    +$85K

    vs. prior 12 months

    Last 12mo awards

    11 awards

    18 actions

    Historical and award details for WERFEN USA LLC
    Obligations: prior → latest
    $338K → $424K
    +25.3%
    Share: prior → latest
    0.72% → 2.8%
    +2.1 percentage points
    All-period obligations
    $1.0M
    0.080% of all-period positive obligations · 29 awards
    Recorded activity
    Since May 15, 2023
    through Jul 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside13
    Not reported1011
    Reported small business00
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $323K

    2.1%

    Dollar movement

    +$304K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    4 actions

    Historical and award details for DIASORIN INC
    Obligations: prior → latest
    $19K → $323K
    +1635.9%
    Share: prior → latest
    0.040% → 2.1%
    +2.1 percentage points
    All-period obligations
    $1.2M
    0.090% of all-period positive obligations · 5 awards
    Recorded activity
    Since Aug 24, 2022
    through Jul 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $303K

    2.0%

    Dollar movement

    −$206K

    vs. prior 12 months

    Last 12mo awards

    5 awards

    6 actions

    Historical and award details for ROCHE DIABETES CARE INC
    Obligations: prior → latest
    $508K → $303K
    −40.4%
    Share: prior → latest
    1.1% → 2.0%
    +0.9 percentage points
    All-period obligations
    $2.1M
    0.16% of all-period positive obligations · 21 awards
    Recorded activity
    Since Nov 29, 2021
    through Feb 10, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported55
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $296K

    1.9%

    Dollar movement

    +$350K

    vs. prior 12 months

    Last 12mo awards

    19 awards

    22 actions

    Historical and award details for FISHER SCIENTIFIC COMPANY L.L.C.
    Obligations: prior → latest
    −$55K → $296K
    Not comparable
    Share: prior → latest
    0% → 1.9%
    +1.9 percentage points
    All-period obligations
    $3.4M
    0.25% of all-period positive obligations · 114 awards
    Recorded activity
    Since Nov 10, 2021
    through Jul 7, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside63
    Not reported1337
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $277K

    1.8%

    Dollar movement

    +$207K

    vs. prior 12 months

    Last 12mo awards

    3 awards

    5 actions

    Historical and award details for OXFORD NANOPORE TECHNOLOGIES INC
    Obligations: prior → latest
    $70K → $277K
    +295.4%
    Share: prior → latest
    0.15% → 1.8%
    +1.7 percentage points
    All-period obligations
    $358K
    0.030% of all-period positive obligations · 5 awards
    Recorded activity
    Since Sep 8, 2023
    through Jun 23, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside31
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $272K

    1.8%

    Dollar movement

    +$234K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    2 actions

    Historical and award details for GOVERNMENT SCIENTIFIC SOURCE INC
    Obligations: prior → latest
    $38K → $272K
    +615.2%
    Share: prior → latest
    0.080% → 1.8%
    +1.7 percentage points
    All-period obligations
    $732K
    0.050% of all-period positive obligations · 17 awards
    Recorded activity
    Since Oct 26, 2021
    through Sep 22, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside10
    Reported no set-aside11
    Not reported00
    Reported small business21
    All-period set-aside types
    • 7 · Total small business
  12. #12

    Last 12mo obligations

    $271K

    1.8%

    Dollar movement

    −$78K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    9 actions

    Historical and award details for REMEL INC.
    Obligations: prior → latest
    $349K → $271K
    −22.3%
    Share: prior → latest
    0.74% → 1.8%
    +1.1 percentage points
    All-period obligations
    $1.8M
    0.13% of all-period positive obligations · 54 awards
    Recorded activity
    Since Nov 30, 2021
    through Jul 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside34
    Not reported55
    Reported small business01
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $258K

    1.7%

    Dollar movement

    +$94K

    vs. prior 12 months

    Last 12mo awards

    2 awards

    13 actions

    Historical and award details for MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC
    Obligations: prior → latest
    $164K → $258K
    +57.6%
    Share: prior → latest
    0.35% → 1.7%
    +1.4 percentage points
    All-period obligations
    $624K
    0.050% of all-period positive obligations · 3 awards
    Recorded activity
    Since May 1, 2023
    through Jun 30, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $249K

    1.6%

    Dollar movement

    +$249K

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for SPEED BIOSYSTEMS, LLC
    Obligations: prior → latest
    $0 → $249K
    Not comparable
    Share: prior → latest
    0% → 1.6%
    +1.6 percentage points
    All-period obligations
    $933K
    0.070% of all-period positive obligations · 5 awards
    Recorded activity
    Since Jan 19, 2022
    through Sep 25, 2025

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $225K

    1.5%

    Dollar movement

    +$225K

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for CERUS CORPORATION
    Obligations: prior → latest
    $0 → $225K
    Not comparable
    Share: prior → latest
    0% → 1.5%
    +1.5 percentage points
    All-period obligations
    $225K
    0.020% of all-period positive obligations · 1 award
    Recorded activity
    Since Mar 3, 2026
    through Apr 13, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

Recompete watch for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

SIRO DIAGNOSTICS, INC.

ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND

The reported potential end date moved later 3 times in the latest 12 months.

Performance period

94.4%

As of Jul 27, 2026Potential end Sep 30, 2026

Current award value as a share of potential value

99.7%

$28.3M current$28.4M potential
Supporting data

Reported performance starts Aug 2, 2023.

No later potential end date is reported; current and potential end dates are both Sep 30, 2026.

$28.3M is obligated against $28.3M in current reported award value (100.0%).

Reported potential end dates: Dec 31, 2025 → Mar 31, 2026 → Jun 30, 2026 → Sep 30, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50123C00036

These are research leads, not confirmed recompetes. USAspending records through Jul 27, 2026; reported dates and values can change through later modifications.

Award activity for In-Vitro Diagnostic Substance Manufacturing at the Department of Health and Human Services

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Deobligation

This action

−$1.6M

BIOTEKE USA, LLC

ASPR/DAAPPO/ORM HQ

THIS BILATERAL MODIFICATION INCORPORATES THE SETTLEMENT AGREEMENT EXECUTED ON AUGUST 15, 2025 AND DE-OBLIGATE POST SETTLEMENT REMAINING FUNDS.

Why it stands out

This award recorded a material contraction.

The action removed $1.6M. A deobligation does not by itself show lower requirement demand.

Award net obligations
$2.1M
Share of 12-month positive obligations
10.6%
Supporting data
Prime contractor
0% share
−7.8 percentage points · $5.3M net decline; action accounted for 30.4%
Funding office
0% attributed share
$1.6M net decline; action accounted for 100.0%
Related:Largest net deobligation
PIID 75A50424C00003 · Mod P00002
Base award

This action

+$1.8M

CEPHEID

PHOENIX AREA INDIAN HEALTH SVC

NEW BPA CALL FOR CEPHEID SUPPLIES

Why it stands out

The contractor climbed 3 positions in this market.

It now ranks #1 by positive obligations over the latest 12 months.

Award net obligations
$1.8M
Share of 12-month positive obligations
11.9%
Supporting data
Prime contractor
#1 · 34.1% share
up 3 ranks · +30.7 percentage points · $3.6M net increase; action accounted for 50.7%
Funding office
#1 · 28.3% attributed share
+28.3 percentage points · $5.7M net increase; action accounted for 31.7%
Related:Largest share gain
PIID 75H71226F28028
Deobligation

This action

−$684K

ILLUMINA, INC.

FDA OFFICE OF ACQ GRANT SVCS

ILLUMINA REAGENT CHEMISTRY KITS

Why it stands out

This award recorded a material contraction.

The action removed $684K. A deobligation does not by itself show lower requirement demand.

Award net obligations
$682K
Share of 12-month positive obligations
4.5%
Supporting data
Prime contractor
#2 · 12.1% share
up 1 rank · +7.2 percentage points · $480K net decline; action exceeded it by $204K
Funding office
#3 · 14.3% attributed share
down 1 rank · +8.4 percentage points · $592K net decline; action exceeded it by $92K
PIID 75F40125F19055 · Mod P00002
Deobligation

This action

−$933K

BIOMERIEUX INC

PHOENIX AREA INDIAN HEALTH SVC

CLOSEOUT

Why it stands out

The award contracted while office-attributed spending grew overall.

The action removed $933K while office-attributed spending rose $5.7M.

Award net obligations
$283K
Share of 12-month positive obligations
6.2%
Supporting data
Prime contractor
#3 · 6.5% share
up 3 ranks · +3.6 percentage points · $395K net decline; action exceeded it by $539K
Funding office
#1 · 28.3% attributed share
$5.7M net increase despite this negative action
PIID 75H71224F28001 · Mod P00001
Base award

This action

+$610K

FISHER SCIENTIFIC COMPANY L.L.C.

ALBUQUERQUE AREA INDIAN HEALTH SVC

AAO/AAIHS- LABORATORY REAGENTS/SUPPLIES.

Why it stands out

The funding office climbed 4 positions in attributed spending.

It now ranks #2 in attributed spending.

Award net obligations
$610K
Share of 12-month positive obligations
4.0%
PIID 75H70726F80013
Deobligation

This action

−$345K

BIOFIRE DIAGNOSTICS LLC

NATIONAL INSTITUTES OF HEALTH - CC

TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.

Why it stands out

The award contracted while the contractor grew overall.

The action removed $345K while the contractor rose $1.2M.

Award net obligations
$1.3M
Share of 12-month positive obligations
2.3%
Supporting data
Prime contractor
0% share
$1.2M net increase despite this negative action
Funding office
#5 · 6.9% attributed share
down 1 rank · +2.5 percentage points · $1.0M net decline; action accounted for 34.1%
PIID HHSN269201700022U · Mod P00007
View recent award activity by date (10)
  1. QIAGEN, LLCDeobligation · PIID 75F40125F19006
    Action−$2
    Award net obligations$34K
  2. SIEMENS HEALTHCARE DIAGNOSTICS INC.Deobligation · PIID 75H71025P00408
    Action−$17K
    Award net obligations$0
  3. ILLUMINA, INC.Base award · PIID 75F40126F19078
    Action+$44K
    Award net obligations$44K
  4. BIOMERIEUX INCBase award · PIID 75H71226F28008
    Action+$35K
    Award net obligations$35K
  5. LONZA WALKERSVILLE, INCDeobligation · PIID 75N94021P00489
    Action>−$1
    Award net obligations$19K
  6. LUMINEX CORPModification · PIID 75D30124P18498
    Action+$8K
    Award net obligations$24K
  7. BIOMERIEUX INCDeobligation · PIID 75H71224F28001
    Action−$933K
    Award net obligations$283K
  8. BIO RAD LABORATORIES INCDeobligation · PIID 75H71023P01671
    Action−$18K
    Award net obligations$145K
  9. BIOMERIEUX INCModification · PIID 75H71223P00151
    Action+$14K
    Award net obligations$55K
  10. ILLUMINA, INC.Deobligation · PIID 75F40125F19055
    Action−$2K
    Award net obligations$682K

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology